We observed significant correlation between DNMT3A mutation and CpG hypomethylation in the TCGA AML cohort, with 19,235 hypomethylated sites reaching statistical significance at P < 0.018 (Supplementary Fig. 14). The gene discussed is DNMT3A; the disease is acute myeloid leukemia.